| Cytokines and major depression OJG Schiepers, MC Wichers, M Maes Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (2), 201-217, 2005 | 1602 | 2005 |
| So depression is an inflammatory disease, but where does the inflammation come from? M Berk, LJ Williams, FN Jacka, A O’Neil, JA Pasco, S Moylan, NB Allen, ... BMC medicine 11 (1), 200, 2013 | 1531 | 2013 |
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors M Berk, F Kapczinski, AC Andreazza, OM Dean, F Giorlando, M Maes, ... Neuroscience & biobehavioral reviews 35 (3), 804-817, 2011 | 1336 | 2011 |
| A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness M Maes, P Galecki, YS Chang, M Berk Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 676-692, 2011 | 1312 | 2011 |
| Evidence for an immune response in major depression: a review and hypothesis M Maes Progress in Neuro-Psychopharmacology and Biological Psychiatry 19 (1), 11-38, 1995 | 1253 | 1995 |
| Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies CA Köhler, TH Freitas, M Maes, NQ De Andrade, CS Liu, BS Fernandes, ... Acta Psychiatrica Scandinavica 135 (5), 373-387, 2017 | 1202 | 2017 |
| The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression M Maes, R Yirmyia, J Noraberg, S Brene, J Hibbeln, G Perini, M Kubera, ... Metabolic brain disease 24, 27-53, 2009 | 1117 | 2009 |
| The serotonin hypothesis of major depression M Maes Psychopharmacology: The fourth generation of progress, 933-944, 1995 | 1037 | 1995 |
| The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety M Maes, C Song, A Lin, R De Jongh, A Van Gastel, G Kenis, E Bosmans, ... Cytokine 10 (4), 313-318, 1998 | 1010 | 1998 |
| Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the … B Leonard, M Maes Neuroscience & Biobehavioral Reviews 36 (2), 764-785, 2012 | 946 | 2012 |
| Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression M Maes, E Bosmans, R De Jongh, G Kenis, E Vandoolaeghe, H Neels Cytokine 9 (11), 853-858, 1997 | 898 | 1997 |
| Major depression and activation of the inflammatory response system M Maes Cytokines, stress, and depression, 25-46, 1999 | 853 | 1999 |
| Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression M Maes, HY Meltzer, E Bosmans, R Bergmans, E Vandoolaeghe, ... Journal of affective disorders 34 (4), 301-309, 1995 | 817 | 1995 |
| The new ‘5-HT’hypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis … M Maes, BE Leonard, AM Myint, M Kubera, R Verkerk Progress in neuro-psychopharmacology and biological psychiatry 35 (3), 702-721, 2011 | 781 | 2011 |
| The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in … M Mass, M Kubera, JC Leunis Neuroendocrinology Letters 29 (1), 117-124, 2008 | 756 | 2008 |
| Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways M Maes, M Berk, L Goehler, C Song, G Anderson, P Gałecki, B Leonard BMC medicine 10, 1-19, 2012 | 682 | 2012 |
| Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression M Maes Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (3), 664-675, 2011 | 643 | 2011 |
| Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy L Capuron, A Ravaud, PJ Neveu, AH Miller, M Maes, R Dantzer Molecular psychiatry 7 (5), 468-473, 2002 | 635 | 2002 |
| Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients M Maes, A Christophe, J Delanghe, C Altamura, H Neels, HY Meltzer Psychiatry research 85 (3), 275-291, 1999 | 635 | 1999 |
| The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications S Moylan, M Maes, NR Wray, M Berk Molecular psychiatry 18 (5), 595-606, 2013 | 626 | 2013 |
Décio Sabbatini BarbosaProfessor de Bioquímica Clínica, Universidade Estadual de Londrina在 uel.br 的电子邮件经过验证
